Company
Institut de l’audition
Institut de l'Audition is a research center jointly operated by Institut Pasteur and Inserm dedicated to hearing health through fundamental and translational neuroscience. It conducts basic research on auditory system function, develops innovative diagnostic and therapeutic approaches for hearing disorders across all ages, and disseminates findings to the scientific community and healthcare professionals. The institute also operates the CeRIAH center for audiology research and collaborates with hospitals and audiologists across France.
Institut de l’audition is a privately held company operating in the medicine sector, based in France. Leadership tracked by CEOInsider includes Anne-Lise Giraud (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage of Institut de l'Audition has focused on neurotechnology and hearing research, including work on brain-computer interfaces for speech decoding and the spatial-frequency tuning of neural activity involved in imagined speech. The institution has also been featured in connection with clinical advances in hearing loss treatment, including France's first gene therapy trial for pediatric hearing loss.
Summarized from the headlines in the sidebar; see each source for the full story.